Before Sen. Joe Manchin (D-WV) put the final kibosh on the Build Back Better Act late last year, Democrats had never been so close to passing major drug pricing reforms.
But after that bill died in the Senate, even as Manchin vowed to back such pricing reforms, reaching 50 votes to pass a bill under reconciliation seemed to be stretching out of reach as the congressional summer recess nears and as midterm elections approach.
Now, however, President Joe Biden is signaling an 11th-hour push is coming around drug prices, with plans to not only allow Medicare to negotiate, but to make insulin affordable too. The House in late March passed a bill to cap insulin prices at $35 per month but the Senate has yet to vote on the bill.
Click here to view original post